Joseph Truluck - 25 Mar 2024 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Financial Officer
Signature
/s/ Joseph Truluck
Issuer symbol
ADIL
Transactions as of
25 Mar 2024
Net transactions value
$0
Form type
4
Filing time
27 Mar 2024, 18:07:38 UTC
Previous filing
25 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 25 Mar 2024 Common Stock 25,000 $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.